Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 43

Sort by

Sort Order Select

Journal Articles

Characterization of Cases with the Rare Cytogenetic Abnormality I(7)(p10) Reveals an Association with IDH2 Mutated Acute Myeloid Leukemia

Anna Stengel, Manja Meggendorfer, Constance Regina Baer, Niroshan Nadarajah, Stephan Hutter, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach

Blood (2023) 142 (Supplement 1): 5987.

https://doi.org/10.1182/blood-2023-179844

Published: 2023

Journal Articles

Proposal ofmyeloid Neoplasms with MYC -Positive Double Minutes As a Distinct Entity

Isolde Summerer, Wencke Walter, Manja Meggendorfer, Torsten Haferlach, Frank Dicker, Stephan Hutter, Niroshan Nadarajah, Constance Regina Baer, Anna Stengel, Wolfgang Kern, John M. Bennett, Claudia Haferlach, Christian Pohlkamp

Blood (2023) 142 (Supplement 1): 2930.

https://doi.org/10.1182/blood-2023-189902

Published: 2023

Journal Articles

Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia

Blood (2023) 141 (13): 1640–1644.

https://doi.org/10.1182/blood.2022017249

Published: 2023

Includes: Supplemental data

Journal Articles

Interplay of TP53 Allelic State, Blast Count and Karyotype on Survival of Patients with AML and MDS

Anna Stengel, Manja Meggendorfer, Wencke Walter, Constance Baer, Niroshan Nadarajah, Stephan Hutter, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach

Blood (2022) 140 (Supplement 1): 2073–2074.

https://doi.org/10.1182/blood-2022-159388

Published: 2022

Journal Articles

RUNX1 Mutated AML and MDS: Similarities, Differences and Molecular Factors Leading to Disease Progression

Anna Stengel, Manja Meggendorfer, Wencke Walter, Constance Baer, Niroshan Nadarajah, Stephan Hutter, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach

Blood (2022) 140 (Supplement 1): 2990–2991.

https://doi.org/10.1182/blood-2022-159379

Published: 2022

Journal Articles

Myeloid Neoplasms with MYC -Positive Double Minutes, a Specific Subgroup?

Isolde Summerer, Wencke Walter, Manja Meggendorfer, Torsten Haferlach, Stephan Hutter, Niroshan Nadarajah, Constance Baer, Anna Stengel, Wolfgang Kern, Claudia Haferlach

Blood (2022) 140 (Supplement 1): 9142–9143.

https://doi.org/10.1182/blood-2022-166102

Published: 2022

Journal Articles

IDH2 mutations in Hematological Malignancies: Distribution, Hot Spots, Clonal Development and Identification of a Novel (cyto-)Genetically Defined Subgroup

Anna Stengel, Manja Meggendorfer, Wencke Walter, Constance Baer, Niroshan Nadarajah, Stephan Hutter, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach

Blood (2022) 140 (Supplement 1): 3405–3406.

https://doi.org/10.1182/blood-2022-158979

Published: 2022

Journal Articles

Benchmarking of Whole Genome Sequencing (WGS) and Whole Transcriptome Sequencing (WTS) As Diagnostic Tools for the Genetic Characterization of Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL) in Adults

Claudia Haferlach, Wencke Walter, Manja Meggendorfer, Anna Stengel, Constance Baer, Stephan Hutter, Niroshan Nadarajah, Heiko Müller, Wolfgang Kern, Torsten Haferlach

Blood (2021) 138 (Supplement 1): 273.

https://doi.org/10.1182/blood-2021-150260

Published: 2021

Journal Articles

TP53 Mutations, Deletions, and CN-LOH: Comparison of TP53 single Hit and Double Hit Events and Their Impact on Prognosis in Hematological Malignancies

Anna Stengel, Heiko Müller, Manja Meggendorfer, Wencke Walter, Constance Baer, Niroshan Nadarajah, Stephan Hutter, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach

Blood (2021) 138 (Supplement 1): 2224.

https://doi.org/10.1182/blood-2021-150354

Published: 2021

Journal Articles

Enhancer Hijacking of BCL11B Defines a Subtype of Lineage Ambiguous Acute Leukemia

Blood (2020) 136 (Supplement_2): LBA-3.

https://doi.org/10.1182/blood-2020-143881

Published: 2020

Journal Articles

Mutational Patterns and Correlation to Chip-Related Mutations in Hematological Malignancies - a Study on Mutation Frequencies of 122 Genes in 28 Entities Including 3096 Cases

Anna Stengel, PhD, Constance Baer, PhD, Wencke Walter, PhD, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-136288

Published: 2020

Journal Articles

Artificial Intelligence Substantially Supports Chromosome Banding Analysis Maintaining Its Strengths in Hematologic Diagnostics Even in the Era of Newer Technologies

Claudia Haferlach, MD, Siegfried Hänselmann, PhD, Wencke Walter, PhD, Sarah Volkert, Melanie Zenger, Wolfgang Kern, MD, Anna Stengel, PhD, Thomas Lörch, PhD, Torsten Haferlach, MD

Blood (2020) 136 (Supplement 1): 47–48.

https://doi.org/10.1182/blood-2020-137463

Published: 2020

Journal Articles

The Potential of Molecular Genetic Analysis for Diagnostic and Prognostic Decision Making in Clonal Cytopenia of Undetermined Significance (CCUS) and MDS - a Study on 576 Patients

Constance Baer, PhD, Anna Stengel, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-136557

Published: 2020

Journal Articles

T-Cell Acute Lymphoblastic Leukemia Can be Subdivided into Six Genetically Distinct Subtypes with Prognostic Impact By Combination of Whole Genome and Whole Transcriptome Data

Janine Müller, PhD, Claudia Haferlach, MD, Henning Ruge, PhD, Heiko Müller, PhD, Irene Fuhrmann, Manja Meggendorfer, PhD, Martha-Lena Müller, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Anna Stengel, PhD

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-136554

Published: 2020

Journal Articles

Correlation of Mutation Patterns with Patient Age in 2656 Cases with 11 Different Hematological Malignancies

Anna Stengel, PhD, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-136545

Published: 2020

Journal Articles

The Diverse Landscape of Fusion Transcripts in 25 Different Hematological Entities

Claudia Haferlach, MD, Wencke Walter, PhD, Manja Meggendorfer, PhD, Constance Baer, PhD, Anna Stengel, PhD, Stephan Hutter, PhD, Niroshan Nadarajah, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-137518

Published: 2020

Journal Articles

Comprehensive Analysis of 22 Cases with Blastic Plasmacytoid Dendritic Cell Neoplasm Reveals Mutations in DNA Repair Genes and Two Distinct Subgroups Defined By Differential Gene Expression with Prognostic Impact

Anna Stengel, PhD, Wencke Walter, PhD, Constance Baer, PhD, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD

Blood (2019) 134 (Supplement_1): 1234.

https://doi.org/10.1182/blood-2019-125645

Published: 2019

Journal Articles

Molecular Classification of AML-MRC Reveals a Distinct Profile and Identifies MRC-like Patients with Poor Overall Survival

Constance Baer, PhD, Wencke Walter, PhD, Anna Stengel, PhD, Stephan Hutter, PhD, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD, Torsten Haferlach, MD

Blood (2019) 134 (Supplement_1): 2735.

https://doi.org/10.1182/blood-2019-128234

Published: 2019

Journal Articles

Comprehensive Analysis of MYC Translocations in Multiple Myeloma By Whole Genome Sequencing and Whole Transcriptome Sequencing

Sonja Seliger, Verena Geirhos, Torsten Haferlach, MD, Wolfgang Kern, MD, Wencke Walter, PhD, Manja Meggendorfer, PhD, Constance Baer, PhD, Anna Stengel, PhD, Claudia Haferlach, MD

Blood (2019) 134 (Supplement_1): 1774.

https://doi.org/10.1182/blood-2019-124704

Published: 2019

Journal Articles

Primary and Secondary Hematological Neoplasms - Are They Related?

Claudia Haferlach, MD, Constance Baer, PhD, Stephan Hutter, PhD, Anna Stengel, PhD, Niroshan Nadarajah, Wencke Walter, PhD, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2019) 134 (Supplement_1): 1702.

https://doi.org/10.1182/blood-2019-126585

Published: 2019

NARROW

Characterization of Cases with the Rare Cytogenetic Abnormality I(7)(p10) Reveals an Association with IDH2 Mutated Acute Myeloid Leukemia

Proposal ofmyeloid Neoplasms with MYC -Positive Double Minutes As a Distinct Entity

Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia

Interplay of TP53 Allelic State, Blast Count and Karyotype on Survival of Patients with AML and MDS

RUNX1 Mutated AML and MDS: Similarities, Differences and Molecular Factors Leading to Disease Progression

Myeloid Neoplasms with MYC -Positive Double Minutes, a Specific Subgroup?

IDH2 mutations in Hematological Malignancies: Distribution, Hot Spots, Clonal Development and Identification of a Novel (cyto-)Genetically Defined Subgroup

Benchmarking of Whole Genome Sequencing (WGS) and Whole Transcriptome Sequencing (WTS) As Diagnostic Tools for the Genetic Characterization of Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL) in Adults

TP53 Mutations, Deletions, and CN-LOH: Comparison of TP53 single Hit and Double Hit Events and Their Impact on Prognosis in Hematological Malignancies

Enhancer Hijacking of BCL11B Defines a Subtype of Lineage Ambiguous Acute Leukemia

Mutational Patterns and Correlation to Chip-Related Mutations in Hematological Malignancies - a Study on Mutation Frequencies of 122 Genes in 28 Entities Including 3096 Cases

Artificial Intelligence Substantially Supports Chromosome Banding Analysis Maintaining Its Strengths in Hematologic Diagnostics Even in the Era of Newer Technologies

The Potential of Molecular Genetic Analysis for Diagnostic and Prognostic Decision Making in Clonal Cytopenia of Undetermined Significance (CCUS) and MDS - a Study on 576 Patients

T-Cell Acute Lymphoblastic Leukemia Can be Subdivided into Six Genetically Distinct Subtypes with Prognostic Impact By Combination of Whole Genome and Whole Transcriptome Data

Correlation of Mutation Patterns with Patient Age in 2656 Cases with 11 Different Hematological Malignancies

The Diverse Landscape of Fusion Transcripts in 25 Different Hematological Entities

Comprehensive Analysis of 22 Cases with Blastic Plasmacytoid Dendritic Cell Neoplasm Reveals Mutations in DNA Repair Genes and Two Distinct Subgroups Defined By Differential Gene Expression with Prognostic Impact

Molecular Classification of AML-MRC Reveals a Distinct Profile and Identifies MRC-like Patients with Poor Overall Survival

Comprehensive Analysis of MYC Translocations in Multiple Myeloma By Whole Genome Sequencing and Whole Transcriptome Sequencing

Primary and Secondary Hematological Neoplasms - Are They Related?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only